Evidence map›Paper›PMID 38588528›Full record

ArticleJMIR research protocols2024

Assessing and Improving the Care of Patients With Heart Failure in Ghana: Protocol for a Prospective Observational Study and the Ghana Heart Initiative-Heart Failure Registry.

Felix Awindaogo, Emmanuel Acheamfour-Akowuah, Alfred Doku, Collins Kokuro, Francis Agyekum, Isaac Kofi Owusu

Open access · goldAbstract read
In one paragraph

Article in JMIR research protocols, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 62% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Felix AwindaogoKorle-Bu Teaching Hospital, Accra, Ghana.ORCID https://orcid.org/0000-0002-2612-2685
Emmanuel Acheamfour-AkowuahDirectorate of Medicine Kumasi, Komfo Anokye Teaching Hospital, Kumasi, Ghana.ORCID https://orcid.org/0009-0009-0358-8106
Alfred DokuDepartment of Medicine and Therapeutics, University of Ghana Medical School, University of Ghana, Accra, Ghana.ORCID https://orcid.org/0000-0003-4535-8965
Collins Kokuro *Department of Medicine, School of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.ORCID https://orcid.org/0000-0002-7568-3024
Francis Agyekum *Department of Medicine and Therapeutics, University of Ghana Medical School, University of Ghana, Accra, Ghana.ORCID https://orcid.org/0000-0002-7901-168X
Isaac Kofi OwusuDepartment of Medicine, School of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.ORCID https://orcid.org/0000-0002-8934-8542
Kwame Nkrumah University of Science and Technology · GHUniversity of Ghana · GHKomfo Anokye Teaching Hospital · GHKorle Bu Teaching Hospital · GH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHeart failure (HF) is a leading cause of morbidity and mortality globally, with a high disease burden. The prevalence of HF in Ghana is increasing rapidly, but epidemiological profiles, treatment patterns, and survival data are scarce. The national capacity to diagnose and manage HF appropriately is also limited. To address the growing epidemic of HF, it is crucial to recognize the epidemiological characteristics and medium-term outcomes of HF in Ghana and improve the capability to identify and manage HF promptly and effectively at all levels of care.

objectiveThis study aims to determine the epidemiological characteristics and medium-term HF outcomes in Ghana.

methodsWe conducted a prospective, multicenter, multilevel cross-sectional observational study of patients with HF from January to December 2023. Approximately 5000 patients presenting with HF to 9 hospitals, including teaching, regional, and municipal hospitals, will be recruited and evaluated according to a standardized protocol, including the use of an echocardiogram and an N-terminal pro-brain natriuretic peptide (NT-proBNP) test. Guideline-directed medical treatment of HF will be initiated for 6 months, and the medium-term outcomes of interventions, including rehospitalization and mortality, will be assessed. Patient data will be collated into a HF registry for continuous assessment and monitoring.

resultsThis intervention will generate the necessary information on the etiology of HF, clinical presentations, the diagnostic yield of various tools, and management outcomes. In addition, it will build the necessary capacity and support for HF management in Ghana. As of July 30, 2023, the training and onboarding of all 9 centers had been completed. Preliminary analyses will be conducted by the end of the second quarter of 2024, and results are expected to be publicly available by the middle of 2024.

conclusionsThis study will provide the necessary data on HF, which will inform decisions on the prevention and management of HF and form the basis for future research.

trial registrationISRCTN Registry (United Kingdom) ISRCTN18216214; https:www.isrctn.com/ISRCTN18216214. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/52616.

Indexed as

clinicalcross-sectionalepidemiologyGhanaheartheart failuremanagementmedium-termmonitoringmortalityoutcomepatient datapreventionprotocolteachingtreatment

Identifiers

PMID38588528
PMCPMC11036190
OpenAlexW4390170192

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.